Skip to main content
. 2017 Jul 22;40(10):855–869. doi: 10.1007/s40264-017-0572-8

Fig. 7.

Fig. 7

Areas of the Pharmacovigilance Risk Assessment Committee (PRAC) strategy to measure the impact of pharmacovigilance activities. ADR adverse drug reaction, PV pharmacovigilance, SM signal management